Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treament of inflammation

Details for Australian Patent Application No. 2008275000 (hide)

Owner ChemoCentryx, Inc.

Inventors Krasinski, Antoni; Ungashe, Solomon; Punna, Sreenivas; Zeng, Yibin; Wang, Qiang

Agent Spruson & Ferguson

Pub. Number AU-A-2008275000

PCT Pub. Number WO2009/009740

Priority 60/949,328 12.07.07 US

Filing date 11 July 2008

Wipo publication date 15 January 2009

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2009/009740 Priority application(s): WO2009/009740

11 February 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Fused heteroaryl pyridyl and phenyl benzenesulfonamides as CCR2 modulators for the treatment of inflammation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008275009-Selectively-releasable adhesives

2008274994-Method of administering a greeting card and lottery game combination